IBM 2013 Annual Report Download - page 111

Download and view the complete annual report

Please find page 111 of the 2013 IBM annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 154

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154

Notes to Consolidated Financial Statements
International Business Machines Corporation and Subsidiary Companies
110
Past Due Financing Receivables
($ in millions)
At December 31, 2013:
Tot a l
Past Due
> 90 Days* Current
Tot a l
Financing
Receivables
Recorded
Investment
> 90 Days
and Accruing
Major markets $ 6 $ 6,789 $ 6,796 $ 5
Growth markets 19 2,181 2,200 11
Total lease receivables $25 $ 8,970 $ 8,996 $16
Major markets $ 9 $10,520 $10,529 $ 6
Growth markets 34 3,979 4,012 18
Total loan receivables $43 $14,499 $14,542 $25
To t a l $68 $23,469 $23,537 $41
* Does not include accounts that are fully reserved.
($ in millions)
At December 31, 2012:
Tot a l
Past Due
> 90 Days* Current
Tot a l
Financing
Receivables
Recorded
Investment
> 90 Days
and Accruing
Major markets $ 8 $ 7,028 $ 7,036 $ 5
Growth markets 11 2,127 2,138 8
Total lease receivables $20 $ 9,154 $ 9,174 $13
Major markets $27 $ 9,639 $ 9,666 $ 8
Growth markets 36 3,634 3,670 31
Total loan receivables $63 $13,273 $13,336 $39
To t a l $82 $22,428 $22,510 $52
* Does not include accounts that are fully reserved.
Troubled Debt Restructurings
The company assessed all restructurings that occurred on or after
January 1, 2012 and determined that there were no troubled debt
restructurings for the years ended December 31, 2012 and 2013.
NOTE G.
PROPERTY, PLANT AND EQUIPMENT
($ in millions)
At December 31: 2013 2012
Land and land improvements $ 706 $ 747
Buildings and building improvements 9,680 9,610
Plant, laboratory and office equipment 28,169 27,731
Plant and other property—gross 38,555 38,088
Less: Accumulated depreciation 25,576 25,234
Plant and other property—net 12,979 12,854
Rental machines 1,920 2,414
Less: Accumulated depreciation 1,078 1,271
Rental machines—net 842 1,142
Total—net $13,821 $13,996
NOTE H.
INVESTMENTS AND SUNDRY ASSETS
($ in millions)
At December 31: 2013 2012
Deferred transition and setup costs
and other deferred arrangements* $1,652 $1,630
Derivatives—noncurrent ** 401 585
Alliance investments
Equity method 110 120
Non-equity method 200 226
Prepaid software 352 306
Long-term deposits 316 318
Other receivables 174 204
Employee benefit-related 392 439
Prepaid income taxes 305 459
Other assets 738 735
To t a l $4,639 $5,021
* Deferred transition and setup costs and other deferred arrangements are related to
Global Services client arrangements. See note A, “Significant Accounting Policies,
on pages 86 and 87 for additional information.
** See note D, “Financial Instruments,” on pages 102 through 106 for the fair value of all
derivatives reported in the Consolidated Statement of Financial Position.